GoalVest Advisory »

Tg Therapeutics shares owned by GoalVest Advisory

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by GoalVest Advisory from 13F filings

Historical chart of GoalVest Advisory investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by GoalVest Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by GoalVest Advisory

Quarter filed Position value Share count Share price at filing
2024-09-30 $31k 1.3k 23.39
2022-06-30 $7.0k 1.3k 5.45

More positions owned by GoalVest Advisory

Vanguard S&p 500 Etf Etf (VOO)
Vanguard Growth Etf Etf (VUG)
Spdr Portfolio Intermediate Term Corporate Bond Etf Etf (SPIB)
Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Small-cap Etf Etf (VB)
Jpmorgan U.s. Quality Factor Etf Etf (JQUA)
Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Spdr Nyse Technology Etf Etf (XNTK)
Ishares Select Dividend Etf Etf (DVY)
Microsoft Corp Stock (MSFT)
Alpha Architect 1-3 Month Box Etf Etf (BOXX)
Tesla Stock (TSLA)
Palantir Technologies Inc Cl A Stock (PLTR)
Nvidia Corporation Stock (NVDA)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)

View all positions for GoalVest Advisory

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Pictet Asset Management Holding SA
Geode Capital Management
Susquehanna International
Soleus Capital Management
Opaleye Management
Morgan Stanley
ClearBridge Advisors
Nuveen Asset Management
Deep Track Capital
Goodman & Company, Investment Counsel
Goldman Sachs Group
Northern Trust

View all funds holding Tg Therapeutics